smt-vec+pd1 (Guangzhou Sinogen Pharmaceutical)

N/A

Report date: 2025/06/11 10:38:46

Base Information

Drug Namesmt-vec+pd1 (Guangzhou Sinogen Pharmaceutical)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionT lymphocytes stimulantsImmunostimulantsProgrammed cell death protein 1 modulators
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangzhou Sinogen Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangzhou Sinogen Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A